These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 10935507)

  • 1. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.
    Ljungman M
    Neoplasia; 2000; 2(3):208-25. PubMed ID: 10935507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction.
    Latonen L; Kurki S; Pitkänen K; Laiho M
    Cell Signal; 2003 Jan; 15(1):95-102. PubMed ID: 12401524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and activities of the p53 tumour suppressor protein.
    Bálint E E; Vousden KH
    Br J Cancer; 2001 Dec; 85(12):1813-23. PubMed ID: 11747320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
    Qiao D; Gaitonde SV; Qi W; Martinez JD
    Carcinogenesis; 2001 Jun; 22(6):957-64. PubMed ID: 11375905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
    DeHaan RD; Yazlovitskaya EM; Persons DL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MDM2-p53 interaction.
    Moll UM; Petrenko O
    Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress.
    Klibanov SA; O'Hagan HM; Ljungman M
    J Cell Sci; 2001 May; 114(Pt 10):1867-73. PubMed ID: 11329373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.
    Khosravi R; Maya R; Gottlieb T; Oren M; Shiloh Y; Shkedy D
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14973-7. PubMed ID: 10611322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and ubiquitination of the tumor suppressor protein p53.
    Jardine LJ; Maki CG
    Methods Mol Biol; 2003; 223():27-38. PubMed ID: 12777718
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells.
    Goetz AW; van der Kuip H; Maya R; Oren M; Aulitzky WE
    Cancer Res; 2001 Oct; 61(20):7635-41. PubMed ID: 11606405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.
    Little NA; Jochemsen AG
    Oncogene; 2001 Jul; 20(33):4576-80. PubMed ID: 11494153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology. Getting p53 out of the nucleus.
    Gottifredi V; Prives C
    Science; 2001 Jun; 292(5523):1851-2. PubMed ID: 11397937
    [No Abstract]   [Full Text] [Related]  

  • 16. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
    Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
    Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.
    Zilfou JT; Hoffman WH; Sank M; George DL; Murphy M
    Mol Cell Biol; 2001 Jun; 21(12):3974-85. PubMed ID: 11359905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
    Joseph TW; Zaika A; Moll UM
    FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
    Brignone C; Bradley KE; Kisselev AF; Grossman SR
    Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.